Duloxetine Hydrochloride API Market

Duloxetine Hydrochloride API Market contains market size and forecasts of Duloxetine Hydrochloride API in global, including the following market information:

Global Duloxetine Hydrochloride API Market Revenue, 2018-2023, 2023-2030, ($ millions)

Global Duloxetine Hydrochloride API Market Sales, 2018-2023, 2023-2030, (Tons)

Global top five Duloxetine Hydrochloride API companies in 2022 (%)

The global Duloxetine Hydrochloride API market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.

Purity Above 99% Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Duloxetine Hydrochloride API include Moehs Iberica Sl, MSN Laboratories, Aurobindo Pharma, RL Fine Chem, Alembic Pharmaceuticals, Zydus Lifesciences, Jubilant Generics, Hetero Drugs and Alkem Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Duloxetine Hydrochloride API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Duloxetine Hydrochloride API Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Duloxetine Hydrochloride API Market Segment Percentages, by Type, 2022 (%)

Purity Above 99%

Purity 99%

Purity Below 99%

Global Duloxetine Hydrochloride API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Duloxetine Hydrochloride API Market Segment Percentages, by Application, 2022 (%)

Tablets

Capsules

Global Duloxetine Hydrochloride API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Duloxetine Hydrochloride API Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Duloxetine Hydrochloride API revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Duloxetine Hydrochloride API revenues share in global market, 2022 (%)

Key companies Duloxetine Hydrochloride API sales in global market, 2018-2023 (Estimated), (Tons)

Key companies Duloxetine Hydrochloride API sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Moehs Iberica Sl

MSN Laboratories

Aurobindo Pharma

RL Fine Chem

Alembic Pharmaceuticals

Zydus Lifesciences

Jubilant Generics

Hetero Drugs

Alkem Laboratories

Esteve Qu?mica SA

SIGNA SA DE CV

Sun Pharmaceutical Industries

Orbion Pharmaceuticals

Wockhardt

Torrent Pharmaceuticals

Mylan Laboratories

Dr. Reddy's Laboratories

Krka

Teva Pharmaceutical Industries

Nosch Labs

Saneca Pharmaceuticals

Shodhana Laboratories

Uni?n Qu?mico Farmac?utica SA

SCI Pharmtech

Shanghai Wonder Pharmacaceutical

Zhejiang Yongtai Technology

HEC Pharm

Zhejiang Liaoyuan Pharmaceutical

Zhejiang Huahai Pharmaceutical